FR2085629A1 - Lead monoxide vitamin f compsn - topical treatment of eczema - Google Patents

Lead monoxide vitamin f compsn - topical treatment of eczema

Info

Publication number
FR2085629A1
FR2085629A1 FR7012180A FR7012180A FR2085629A1 FR 2085629 A1 FR2085629 A1 FR 2085629A1 FR 7012180 A FR7012180 A FR 7012180A FR 7012180 A FR7012180 A FR 7012180A FR 2085629 A1 FR2085629 A1 FR 2085629A1
Authority
FR
France
Prior art keywords
vitamin
compsn
eczema
topical treatment
lead monoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7012180A
Other languages
English (en)
French (fr)
Other versions
FR2085629B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERDIE PIERRETTE
Original Assignee
VERDIE PIERRETTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VERDIE PIERRETTE filed Critical VERDIE PIERRETTE
Priority to FR7012180A priority Critical patent/FR2085629A1/fr
Publication of FR2085629A1 publication Critical patent/FR2085629A1/fr
Application granted granted Critical
Publication of FR2085629B1 publication Critical patent/FR2085629B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/241—Lead; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7012180A 1970-04-03 1970-04-03 Lead monoxide vitamin f compsn - topical treatment of eczema Granted FR2085629A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7012180A FR2085629A1 (en) 1970-04-03 1970-04-03 Lead monoxide vitamin f compsn - topical treatment of eczema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7012180A FR2085629A1 (en) 1970-04-03 1970-04-03 Lead monoxide vitamin f compsn - topical treatment of eczema

Publications (2)

Publication Number Publication Date
FR2085629A1 true FR2085629A1 (en) 1971-12-31
FR2085629B1 FR2085629B1 (enExample) 1973-06-08

Family

ID=9053414

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7012180A Granted FR2085629A1 (en) 1970-04-03 1970-04-03 Lead monoxide vitamin f compsn - topical treatment of eczema

Country Status (1)

Country Link
FR (1) FR2085629A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043558A1 (es) * 1992-06-05 1993-12-16 Arbizu Francisco J Torres Procedimiento para la obtencion de una pomada aplicable en el tratamiento de eccemas.
ES2058026A1 (es) * 1993-02-01 1994-10-16 Asensi Enrique Cerezo Pomada o unguento y metodo para su obtencion, para tratamiento de afecciones cutaneas y subcutaneas de animales y personas.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043558A1 (es) * 1992-06-05 1993-12-16 Arbizu Francisco J Torres Procedimiento para la obtencion de una pomada aplicable en el tratamiento de eccemas.
ES2058026A1 (es) * 1993-02-01 1994-10-16 Asensi Enrique Cerezo Pomada o unguento y metodo para su obtencion, para tratamiento de afecciones cutaneas y subcutaneas de animales y personas.

Also Published As

Publication number Publication date
FR2085629B1 (enExample) 1973-06-08

Similar Documents

Publication Publication Date Title
CA947279A (en) METHOD OF PRODUCING .alpha.-DIPEPTIDE ESTERS OF L-ASPARTIC ACID
CA972749A (en) Derivatives of 9-oxo-15-hydroxyprostanoic acid, homologs thereof and their preparation
OA02553A (fr) Nouveaux dérivés de l'Hydroxy-4 coumarine et leurs procédés de préparation.
FR2085629A1 (en) Lead monoxide vitamin f compsn - topical treatment of eczema
ES402726A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo-(4, 3, 1, 03,7) decanos.
ES415514A1 (es) Procedimiento para preparar derivados de eritromicina acuo-solubles, dulces y agradables.
IT1057859B (it) Perivato del triamoinolone
BE769798A (fr) Preparation d'hydroperoxyde de cyclohexyle par oxydation de cyclohexan
ES404788A1 (es) Un procedimiento para la preparacion de nuevos derivados deacidos xantonacarboxilicos sustituidos.
FR2106984A5 (en) Honey and butter foodstuff - with added vitamins and butter preservative
EP0019000A4 (en) OSTEOPLASTIC PROMOTOR.
GB1336325A (en) Diketones
Haines A history of Protestant missions in Malaya during the nineteenth century
CS162762B2 (en) Method of 1,2,3,6-tetrahydro-4-pyridylmethyl-carboxyl acid's new esters making
SE334357B (enExample)
FR2085632A1 (en) Glycylglycollic acid derivs - hepatoprojectors normolipemiants and hypocholesterol emiants
FR2160246A1 (en) Tannin/methylcellulose compsns - dermatological antiseptics
ES376409A1 (es) Procedimiento para la preparacion de 21-enantato de 9-alfa - fluor-16-fluormetilen-prednisolona.
FR2092649A1 (en) Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid
AU252514B2 (en) Improvements in or relating to methods of producing compounds fromthe vitamin a series and compounds having vitamin a activity obtained by conversion thereof
GB1268008A (en) ESTERS OF p-BYPHENYLYLACETIC ACID
OA00503A (fr) Dérivés hydroxylés et carboxylés hydrosolubles des huiles essentielles, notamment de pin, de niaouli et d'eucalyptus.
GB1368251A (en) Theophylinylmethylethanoic acid ester
AU422761A (en) Improvements in or relating to methods of producing compounds fromthe vitamin a series and compounds having vitamin a activity obtained by conversion thereof
NAKABAYASHI Vitamin C in Black Tea

Legal Events

Date Code Title Description
ST Notification of lapse